Also worth noting the simple but positive reference to Labcon.
"We are also seeing opportunities with end customers through Labcon."
Looking at the on screen ( I appreciate that isn't the full picture) sell side this could move very quickly with the Fuji news expected soon. Would be great to see some consolidation and launch from a higher base. Exciting to think about BCT finally being valued for potential and seeing some further big pharma names on board.
Ann: FY23 Annual Report, page-6
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.002(40.0%) |
Mkt cap ! $3.302M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.3¢ | $29.02K | 6.593M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2349999 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 1889697 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
-0.002 ( 20.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.4¢ | 950761 | ||
| Last updated 15.58pm 13/06/2024 ? | |||||
| BCT (ASX) Chart |